Baillie Gifford & Co’s Aehr Test Systems AEHR Stock Holding History

Baillie Gifford & Co’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.6M	Sell	203,878 -797,140	-80%	-$72.8M	0.02%	182
2026 Q1	$37.1M	Sell	1,001,018 -289,716	-22%	-$9.27M	0.04%	159
2025 Q4	$26.1M	Sell	1,290,734 -239,942	-16%	-$5.8M	0.02%	177
2025 Q3	$46.1M	Sell	1,530,676 -458,737	-23%	-$9.93M	0.03%	154
2025 Q2	$25.7M	Sell	1,989,413 -13,654	-0.7%	-$130K	0.02%	178
2025 Q1	$14.6M	Sell	2,003,067 -20,492	-1%	-$227K	0.01%	196
2024 Q4	$33.7M	Buy	2,023,559 +216,710	+12%	+$2.89M	0.03%	163
2024 Q3	$23.2M	Buy	1,806,849 +136,259	+8%	+$1.97M	0.02%	172
2024 Q2	$18.7M	Buy	1,670,590 +841,964	+102%	+$9.81M	0.01%	185
2024 Q1	$10.3M	Buy	828,626 +166,319	+25%	+$2.77M	0.01%	225
2023 Q4	$17.6M	Buy	662,307 +656,183	+10,715%	+$19.1M	0.01%	196
2023 Q3	$280K	Buy	+6,124	New	+$284K	﹤0.01%	279

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

BIP

Bouvel Investment Partners Phoenixville, Pennsylvania $442M AUM 70.77% 1-Year Est. Return

HIMC

Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return

Baillie Gifford & Co's AEHR Position: Q2 2026 in Review

Baillie Gifford & Co reduced its Aehr Test Systems (AEHR) stake by 80% in Q2 2026, selling an estimated $72.8M and leaving 203,878 shares worth $19.6M. The position accounts for 0.02% of the portfolio, ranked #182.

Baillie Gifford & Co first reported a position in AEHR in Q3 2023 and has held it in 12 quarters since. The position peaked at $46.1M in Q3 2025. 97 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Baillie Gifford & Co held 203,878 shares of Aehr Test Systems worth $19.6M as of Q2 2026.
Baillie Gifford & Co sold 797,140 Aehr Test Systems shares in Q2 2026, an estimated $72.8M.
Aehr Test Systems made up 0.02% of Baillie Gifford & Co's portfolio in Q2 2026, its #182 holding.
Baillie Gifford & Co first reported a position in Aehr Test Systems in Q3 2023 and has held it in 12 quarters since.
Baillie Gifford & Co's Aehr Test Systems position peaked at $46.1M in Q3 2025.
97 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.